“[I]n fiscal year ’04, the DoD paid about $5 million for the year. By fiscal year ’14, it exceeded $514 million, and for fiscal year ’15, we’re on track to exceed $2 billion in expenditures just for compound agents.” Significantly, he said, these compounded drugs make up only 0.5 percent of the total number of prescriptions provided through Tricare. “However, it’s more than 20 percent of our total pharmacy expenditures,” Thomas said, “so you see a huge increase in the expenditures there

quoted from here